INTUITIVE SURGICAL INC (ISRG) Fundamental Analysis & Valuation

NASDAQ:ISRG • US46120E6023

Current stock price

482.22 USD
+3.4 (+0.71%)
At close:
482.7 USD
+0.48 (+0.1%)
After Hours:

This ISRG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. ISRG Profitability Analysis

1.1 Basic Checks

  • ISRG had positive earnings in the past year.
  • In the past year ISRG had a positive cash flow from operations.
  • In the past 5 years ISRG has always been profitable.
  • In the past 5 years ISRG always reported a positive cash flow from operatings.
ISRG Yearly Net Income VS EBIT VS OCF VS FCFISRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • ISRG has a Return On Assets of 13.96%. This is amongst the best in the industry. ISRG outperforms 94.12% of its industry peers.
  • With an excellent Return On Equity value of 16.02%, ISRG belongs to the best of the industry, outperforming 90.37% of the companies in the same industry.
  • ISRG has a Return On Invested Capital of 13.95%. This is amongst the best in the industry. ISRG outperforms 94.65% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ISRG is above the industry average of 9.12%.
  • The last Return On Invested Capital (13.95%) for ISRG is above the 3 year average (12.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROIC 13.95%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ISRG Yearly ROA, ROE, ROICISRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ISRG has a Profit Margin of 28.38%. This is amongst the best in the industry. ISRG outperforms 97.86% of its industry peers.
  • In the last couple of years the Profit Margin of ISRG has grown nicely.
  • ISRG has a better Operating Margin (29.35%) than 96.79% of its industry peers.
  • ISRG's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 66.00%, ISRG is doing good in the industry, outperforming 71.12% of the companies in the same industry.
  • ISRG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.35%
PM (TTM) 28.38%
GM 66%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
ISRG Yearly Profit, Operating, Gross MarginsISRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. ISRG Health Analysis

2.1 Basic Checks

  • ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, ISRG has less shares outstanding
  • ISRG has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ISRG Yearly Shares OutstandingISRG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ISRG Yearly Total Debt VS Total AssetsISRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • ISRG has an Altman-Z score of 40.91. This indicates that ISRG is financially healthy and has little risk of bankruptcy at the moment.
  • ISRG has a better Altman-Z score (40.91) than 96.26% of its industry peers.
  • There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 40.91
ROIC/WACC1.56
WACC8.95%
ISRG Yearly LT Debt VS Equity VS FCFISRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 4.87 indicates that ISRG has no problem at all paying its short term obligations.
  • ISRG has a Current ratio of 4.87. This is in the better half of the industry: ISRG outperforms 73.80% of its industry peers.
  • ISRG has a Quick Ratio of 3.96. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.96, ISRG is in the better half of the industry, outperforming 71.66% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.87
Quick Ratio 3.96
ISRG Yearly Current Assets VS Current LiabilitesISRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ISRG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.92% over the past year.
  • Measured over the past years, ISRG shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.42% on average per year.
  • Looking at the last year, ISRG shows a very strong growth in Revenue. The Revenue has grown by 20.51%.
  • Measured over the past years, ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 18.22% on average per year.
EPS 1Y (TTM)25.92%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%38.12%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%22.96%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.55% on average over the next years. This is quite good.
  • ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.00% yearly.
EPS Next Y14.43%
EPS Next 2Y14.29%
EPS Next 3Y14.44%
EPS Next 5Y13.55%
Revenue Next Year15.78%
Revenue Next 2Y14.84%
Revenue Next 3Y14.6%
Revenue Next 5Y13%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ISRG Yearly Revenue VS EstimatesISRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
ISRG Yearly EPS VS EstimatesISRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

4

4. ISRG Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 50.13, ISRG can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, ISRG is valued a bit cheaper than 65.78% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.42. ISRG is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 41.34 indicates a quite expensive valuation of ISRG.
  • ISRG's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 69.52% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.29, ISRG is valued quite expensively.
Industry RankSector Rank
PE 50.13
Fwd PE 41.34
ISRG Price Earnings VS Forward Price EarningsISRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ISRG is valued a bit cheaper than 66.84% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 71.12% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 68.76
EV/EBITDA 44.77
ISRG Per share dataISRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ISRG does not grow enough to justify the current Price/Earnings ratio.
  • ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as ISRG's earnings are expected to grow with 14.44% in the coming years.
PEG (NY)3.47
PEG (5Y)2.34
EPS Next 2Y14.29%
EPS Next 3Y14.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ISRG Dividend Analysis

5.1 Amount

  • ISRG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ISRG Fundamentals: All Metrics, Ratios and Statistics

INTUITIVE SURGICAL INC

NASDAQ:ISRG (4/24/2026, 8:00:02 PM)

After market: 482.7 +0.48 (+0.1%)

482.22

+3.4 (+0.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-21
Earnings (Next)07-20
Inst Owners88.75%
Inst Owner Change0.17%
Ins Owners0.46%
Ins Owner Change7.52%
Market Cap171.27B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts79.02
Price Target615.86 (27.71%)
Short Float %1.91%
Short Ratio3.67
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)-1.38%
PT rev (3m)-1.27%
EPS NQ rev (1m)-0.79%
EPS NQ rev (3m)-0.7%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)2.86%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)0.51%
Valuation
Industry RankSector Rank
PE 50.13
Fwd PE 41.34
P/S 17.02
P/FCF 68.76
P/OCF 56.52
P/B 9.61
P/tB 9.82
EV/EBITDA 44.77
EPS(TTM)9.62
EY1.99%
EPS(NY)11.66
Fwd EY2.42%
FCF(TTM)7.01
FCFY1.45%
OCF(TTM)8.53
OCFY1.77%
SpS28.34
BVpS50.18
TBVpS49.09
PEG (NY)3.47
PEG (5Y)2.34
Graham Number104.223 (-78.39%)
Profitability
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROCE 16.01%
ROIC 13.95%
ROICexc 20.73%
ROICexgc 21.4%
OM 29.35%
PM (TTM) 28.38%
GM 66%
FCFM 24.75%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 79.72%
Cap/Sales 5.36%
Interest Coverage 250
Cash Conversion 83.46%
Profit Quality 87.21%
Current Ratio 4.87
Quick Ratio 3.96
Altman-Z 40.91
F-Score8
WACC8.95%
ROIC/WACC1.56
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)25.92%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%38.12%
EPS Next Y14.43%
EPS Next 2Y14.29%
EPS Next 3Y14.44%
EPS Next 5Y13.55%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%22.96%
Revenue Next Year15.78%
Revenue Next 2Y14.84%
Revenue Next 3Y14.6%
Revenue Next 5Y13%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year35.45%
EBIT Next 3Y21.62%
EBIT Next 5Y17.23%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%

INTUITIVE SURGICAL INC / ISRG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to ISRG.


What is the valuation status of INTUITIVE SURGICAL INC (ISRG) stock?

ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.


Can you provide the profitability details for INTUITIVE SURGICAL INC?

INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 9 / 10.


Can you provide the expected EPS growth for ISRG stock?

The Earnings per Share (EPS) of INTUITIVE SURGICAL INC (ISRG) is expected to grow by 14.43% in the next year.